2013 New York Consolidated Laws
PBH - Public Health
Article 33 - CONTROLLED SUBSTANCES
Title 1 - (3300 - 3309-A) GENERAL PROVISIONS
3306 - Schedules of controlled substances.


NY Pub Health L § 3306 (2012) What's This?
 
    §  3306.  Schedules  of  controlled  substances.    There  are  hereby
  established five schedules of controlled  substances,  to  be  known  as
  schedules  I,  II,  III,  IV  and  V  respectively. Such schedules shall
  consist of  the  following  substances  by  whatever  name  or  chemical
  designation known:
    Schedule  I.  (a)  Schedule  I  shall  consist  of the drugs and other
  substances, by whatever official name, common or  usual  name,  chemical
  name, or brand name designated, listed in this section.
    (b)  Opiates. Unless specifically excepted or unless listed in another
  schedule, any of the following opiates, including their isomers, esters,
  ethers, salts, and salts of isomers, esters, and  ethers,  whenever  the
  existence  of  such isomers, esters, ethers and salts is possible within
  the specific chemical  designation  (for  purposes  of  3-methylfentanyl
  only, the term isomer includes the optical and geometric isomers):
    (1) Acetyl-alpha-methylfentanyl            (N-{1-(-methyl-2-phenethyl)
  -4-piperidinyl} -N-phenylacetamide.
    (2) Acetylmethadol.
    (3) Allylprodine.
    (4) Alphacetylmethadol (except levo- alphacetylmethadol also known  as
  levo-alpha-acetylmethadol, levomethadylacetate or LAAM).
    (5) Alphameprodine.
    (6) Alphamethadol.
    (7) Alpha-methylfentanyl              (N-{1-(alpha-methyl-beta-phenyl)
  ethyl-4-piperidyl}      propionanilide;       1-(1-methyl-2-phenylethyl)
  -4-(N-propanilido) piperidine).
    (8) Alpha-methylthiofentanyl                 (N-{1-methyl-2)2-thienyl)
  ethyl-4-piperidinyl} -N-phenylpropanamide).
    (9) Beta-hydroxyfentanyl
  (N-{1-2 (2-hydroxy-2-phenethyl)- 4-piperidinyl} -N-phenylpropanamide).
    (10) Beta-hydroxy-3-methylfentanyl      (other       name:       N-{1-
  (2-hydroxy-2-phenethyl) -3-methyl -4-piperidinyl} -N-phenylpropanamide.
    (11) Benzethidine.
    (12) Betacetylmethadol.
    (13) Betameprodine.
    (14) Betamethadol.
    (15) Betaprodine.
    (16) Clonitazene.
    (17) Dextromoramide.
    (18) Diampromide.
    (19) Diethylthiambutene.
    (20) Difenoxin.
    (21) Dimenoxadol.
    (22) Dimepheptanol.
    (23) Dimethylthiambutene.
    (24) Dioxaphetyl butyrate.
    (25) Dipipanone.
    (26) Ethylmethylthiambutene.
    (27) Etonitazene.
    (28) Etoxeridine.
    (29) Furethidine.
    (30) Hydroxypethidine.
    (31) Ketobemidone.
    (32) Levomoramide.
    (33) Levophenacylmorphan.
    (34) 3-Methylfentanyl    (N-{3-methy1-1- (2- phenylethyl -4-piperidyl}
  -N-phenylpropanamide).
    (35) 3-Methylthiofentanyl             (N-{3-methyl-1- (2-thienyl)ethyl
  -4-piperidinyl} -N-phenylpropanamide).

    (36) Morpheridine.
    (37) MPPP (1-methyl -4-phenyl -4-propionoxypiperidine).
    (38) Noracymethadol.
    (39) Norlevorphanol.
    (40) Normethadone.
    (41) Norpipanone.
    (42) Para-fluorofentanyl     (N- (4-fluorophenyl) -N-{1- (2-phenethyl)
  -4-piperidinyl} -propanamide.
    (43) PEPAP (1- (-2-phenethyl) -4-phenyl -4-acetoxypiperidine.
    (44) Phenadoxone.
    (45) Phenampromide.
    (46) Phenomorphan.
    (47) Phenoperidine.
    (48) Piritramide.
    (49) Proheptazine.
    (50) Properidine.
    (51) Propiram.
    (52) Racemoramide.
    (53)  Thiofentanyl  (N-phenyl-N-{1- (2-thienyl) ethyl -4- piperidinyl}
  -propanamide.
    (54) Tilidine.
    (55) Trimeperidine.
    (c)  Opium  derivatives. Unless specifically excepted or unless listed
  in another schedule, any of the following opium derivatives, its  salts,
  isomers,  and  salts  of  isomers  whenever the existence of such salts,
  isomers, and salts of isomers is possible within the  specific  chemical
  designation:
    (1) Acetorphine.
    (2) Acetyldihydrocodeine.
    (3) Benzylmorphine.
    (4) Codeine methylbromide.
    (5) Codeine-N-oxide.
    (6) Cyprenorphine.
    (7) Desomorphine.
    (8) Dihydromorphine.
    (9) Drotebanol.
    (10) Etorphine (except hydrochloride salt).
    (11) Heroin.
    (12) Hydromorphinol.
    (13) Methyldesorphine.
    (14) Methyldihydromorphine.
    (15) Morphine methylbromide.
    (16) Morphine methylsulfonate.
    (17) Morphine-N-oxide.
    (18) Myrophine.
    (19) Nicocodeine.
    (20) Nicomorphine.
    (21) Normorphine.
    (22) Pholcodine.
    (23) Thebacon.
    (d)  Hallucinogenic substances. Unless specifically excepted or unless
  listed  in  another  schedule,  any  material,  compound,  mixture,   or
  preparation, which contains any quantity of the following hallucinogenic
  substances,  or  which  contains any of its salts, isomers, and salts of
  isomers whenever the existence of such  salts,  isomers,  and  salts  of
  isomers  is  possible  within  the  specific  chemical  designation (for
  purposes of this paragraph only, the term "isomer" includes the optical,
  position and geometric isomers):

  (EXPLANATION--Within  the  following  chemical  designations,  character
    symbol  substitutions  were  made from the original text:  "@" = Greek
    alpha, "&" = Greek beta, "'" = prime mark and "/\" = triangle.)
 
    (1) 4-bromo-2, 5-dimethoxy-amphetamine  Some  trade  or  other  names:
  4-bromo-2, 5-dimethoxy-@-methylphenethylamine; 4-bromo-2, 5-DMA.
    (2) 2, 5-dimethoxyamphetamine   Some    trade    or    other    names:
  2, 5-dimethoxy-@-methylphenethylamine; 2, 5-DMA.
    (3) 4-methoxyamphetamine     Some     trade     or     other    names:
  4-methoxy-@-methylphenethylamine; paramethoxyamphetamine, PMA.
    (4) 5-methoxy-3, 4-methylenedioxy - amphetamine.
    (5) 4-methyl-2, 5-dimethoxy-amphetamine Some trade  and  other  names:
  4-methyl-2, 5-dimethoxy-@-methylphenethylamine; "DOM"; and "STP".
    (6) 3, 4-methylenedioxy amphetamine.
    (7) 3, 4, 5-trimethoxy amphetamine.
    (8) Bufotenine Some trade and other names:  3-(&-dimethylaminoethyl)-5
  hydroxindole;                       3-(2-dimethylaminoethyl)- 5-indolol;
  N, N-dimethylserotonin; -5-hydroxy-N, N-dimethyltryptamine; mappine.
    (9) Diethyltryptamine     Some     trade     and     other      names:
  N, N-diethyltryptamine; DET.
    (10) Dimethyltryptamine Some trade or other names: DMT.
    (11) Ibogane  Some  trade and other names: 7-ethyl-6, 6&, 7, 8, 9, 10,
  12, 13-octahydro-2-methoxy-6,  9-methano-5h-pyrido  {1',2':1,2}  azepino
  {5,4-b} indole: tabernanthe iboga.
    (12) Lysergic acid diethylamide.
    (13) Marihuana.
    (14) Mescaline.
    (15) Parahexyl.   Some   trade   or  other  names:  3-Hexyl-1-hydroxy-
  7,8,9,10-tetra hydro-6,6,9-trimethyl-6H-dibenfo{b,d} pyran.
    (16) Peyote. Meaning all  parts  of  the  plant  presently  classified
  botanically  as  Lophophora  williamsii Lemaire, whether growing or not,
  the seeds thereof, any extract from any part of such  plant,  and  every
  compound,  manufacture,  salts,  derivative,  mixture, or preparation of
  such plant, its seeds or extracts.
    (17) N-ethyl-3-piperidyl benzilate.
    (18) N-methyl-3-piperidyl benzilate.
    (19) Psilocybin.
    (20) Psilocyn.
    (21) Tetrahydrocannabinols. Synthetic equivalents  of  the  substances
  contained  in the plant, or in the resinous extractives of cannabis, sp.
  and/or synthetic substances, derivatives, and their isomers with similar
  chemical structure and pharmacological activity such as the following:
    /\1 cis or trans tetrahydrocannabinol, and their optical isomers
    /\6 cis or trans tetrahydrocannabinol, and their optical isomers
    /\3, 4 cis or trans  tetrahydrocannabinol,  and  its  optical  isomers
  (since   nomenclature   of   these  substances  is  not  internationally
  standardized, compounds of these  structures,  regardless  of  numerical
  designation of atomic positions covered).
    (22) Ethylamine  analog  of  phencyclidine. Some trade or other names:
  N-ethyl-1-phenylcyclohexylamine,    (1-phenylcyclohexyl)     ethylamine,
  N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.
    (23) Pyrrolidine  analog  of  phencyclidine. Some trade or other names
  1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.
    (24) Thiophene analog of phencyclidine. Some  trade  or  other  names:
  1-{1-(2-thienyl)-cyclohexyl}-piperidine,        2-thienylanalog       of
  phencyclidine, TPCP, TCP.
    (25) 3,4-methylenedioxymethamphetamine (MDMA).

    (26) 3,4-methylendioxy-N-ethylamphetamine     (also      known      as
  N-ethyl-alpha-methyl-3,4  (methylenedioxy)  phenethylamine, N-ethyl MDA,
  MDE, MDEA.
    (27) N-hydroxy-3,4-methylenedioxyamphetamine     (also     known    as
  N-hydroxy-alpha-methyl-3,4    (methylenedioxy)    phenethylamine,    and
  N-hydroxy MDA.
    (28) 1-{1- (2-thienyl)  cyclohexyl}  pyrrolidine.  Some  other  names:
  TCPY.
    (29) Alpha-ethyltryptamine. Some trade or other names:    etryptamine;
  Monase;  Alpha-ethyl-1H-indole-3-ethanamine;  3- (2-aminobutyl)  indole;
  Alpha-ET or AET.
    (30) 2,5-dimethoxy-4-ethylamphetamine.  Some  trade  or  other  names:
  DOET.
    (31) 4-Bromo-2,5-dimethoxyphenethylamine.  Some  trade or other names:
  2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;   alpha-desmethyl    DOB;
  2C-B, Nexus.
    (32) 2,5-dimethoxy-4-(n)-propylthiophenethylamine     (2C-T-7),    its
  optical isomers, salts and salts of isomers.
    (e) Depressants. Unless specifically  excepted  or  unless  listed  in
  another  schedule, any material, compound, mixture, or preparation which
  contains any quantity of the following substances  having  a  depressant
  effect  on the central nervous system, including its salts, isomers, and
  salts of isomers whenever the existence  of  such  salts,  isomers,  and
  salts of isomers is possible within the specific chemical designation:
    (1) Mecloqualone.
    (2) Methaqualone.
    (3) Phencyclidine.
    (4)  Gamma  hydroxybutyric  acid,  and  salt, hydroxybutyric compound,
  derivative or preparation of gamma hydroxybutyric  acid,  including  any
  isomers,  esters  and  ethers and salts of isomers, esters and ethers of
  gamma hydroxybutyric  acid,  except  gamma-butyrolactone,  whenever  the
  existence  of  such  isomers,  esters  and  ethers and salts is possible
  within the specific chemical.
    (5) Gamma-butyrolactone, including butyrolactone; butyrolactone gamma;
  4-butyrolactone;   2(3H)-furanone    dihydro;    dihydro-2(3H)-furanone;
  tetrahydro-2-furanone;   1,2-butanolide;  1,4-butanolide;  4-butanolide;
  gamma-hydroxybutyric acid lactone;  3-hydroxybutyric  acid  lactone  and
  4-hydroxybutanoic  acid  lactone  with  Chemical Abstract Service number
  (96-48-0) when any such substance is intended for human consumption.
    (6) 1,4    butanediol,    including    butanediol;    butane-1,4-diol;
  1,4-butylene     glyco;     butylene     glycol;    1,4-dihydroxybutane;
  1,4-tetramethylene   glycol;   tetramethylene   glycol;   tetramethylene
  1,4-diol  with Chemical Abstract Service number (110-63-4) when any such
  substance is intended for human consumption.
    (f) Stimulants. Unless  specifically  excepted  or  unless  listed  in
  another  schedule, any material, compound, mixture, or preparation which
  contains any quantity of the following  substances  having  a  stimulant
  effect  on the central nervous system, including its salts, isomers, and
  salts of isomers:
    (1) Fenethylline.
    (2) N-ethylamphetamine.
    (3) (+ -)cis-4-methylaminorex ((+ -)cis-4,5-dihydro-4-methyl -5-phenyl
  -2-oxazolamine).
    (4) N,N-dimethylamphetamine     (also     known     as      N,N-alpha-
  trimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine).
    (5) Methcathinone  (some other names: 2-(methylamino) - propiophenone;
  alpha-(methylamino)   propiophenone;    2-(methylamino) -1-phenylpropan-
  1-one;  alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone,

  N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and  UR1432),
  its salts, optical isomers and salts of optical isomers.
    (6)   Aminorex.   Some   other  names:  aminoxaphen;  2-amino-5-phenyl
  -2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.
    (7)     Cathinone.      Some      trade      or      other      names:
  2-amino-1-phenyl-1-propanone,                  alpha-aminopropiophenone,
  2-aminopropiophenone, and norephedrone.
    (8) N-benzylpiperazine (some other  names:  BZP;  1-benzylpiperazine),
  its optical isomers, salts and salts of isomers.
    * (9) 4-Methylmethcathinone, also known as Mephedrone.
    * NB Effective until December 11, 2013
    * (9)  4-methyl-N-methylcathinone or 4-Methylmethcathinone, also known
  as Mephedrone.
    * NB Effective December 11, 2013
    * (10) Methylenedioxypyrovalerone, also known as MDPV.
    * (10) 3,4-methylenedioxypyrovalerone  or  Methylenedioxypyrovalerone,
  also known as MDPV.
    * NB Effective December 11, 2013
    * (11)   3,4-methylenedioxy-N-methylcathinone   (some   other   names:
  methylone).
    * NB Effective December 11, 2013
    * (12) 4-Methoxymethcathinone.
    * NB Effective December 11, 2013
    * (13) 3-Fluoromethcathinone.
    * NB Effective December 11, 2013
    * (14) 4-Fluoromethcathinone.
    * NB Effective December 11, 2013
    * (15) Ethylpropion (Ethcathinone).
    * NB Effective December 11, 2013
    * (16) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
    * NB Effective December 11, 2013
    * (17) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
    * NB Effective December 11, 2013
    * (18) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).
    * NB Effective December 11, 2013
    * (19) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).
    * NB Effective December 11, 2013
    * (20) 2-{4-(Ethylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-2).
    * NB Effective December 11, 2013
    * (21) 2-{4-(Isopropylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-4).
    * NB Effective December 11, 2013
    * (22) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).
    * NB Effective December 11, 2013
    * (23) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).
    * NB Effective December 11, 2013
    * (24) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).
    * NB Effective December 11, 2013
    Schedule II. (a) Schedule II shall consist  of  the  drugs  and  other
  substances,  by  whatever  official name, common or usual name, chemical
  name, or brand name designated, listed in this section.
    (b)  Substances,  vegetable  origin  or  chemical  synthesis.   Unless
  specifically  excepted  or unless listed in another schedule, any of the
  following  substances  whether  produced  directly  or   indirectly   by
  extraction  from  substances  of  vegetable  origin, or independently by
  means of chemical synthesis, or  by  a  combination  of  extraction  and
  chemical synthesis:
    (1)   Opium  and  opiate,  and  any  salt,  compound,  derivative,  or
  preparation of opium  or  opiate,  excluding  apomorphine,  dextrorphan,

  nalbuphine,  nalmefene,  naloxone,  and naltrexone, and their respective
  salts, but including the following:
    1. Raw opium.
    2. Opium extracts.
    3. Opium fluid.
    4. Powdered opium.
    5. Granulated opium.
    6. Tincture of opium.
    7. Codeine.
    8. Ethylmorphine.
    9. Etorphine hydrochloride.
    10. Hydrocodone (also known as dihydrocodeinone).
    11. Hydromorphone.
    12. Metopon.
    13. Morphine.
    14. Oxycodone.
    15. Oxymorphone.
    16. Thebaine.
    17. Dihydroetorphine.
    18. Oripavine.
    (2)  Any  salt,  compound, derivative, or preparation thereof which is
  chemically equivalent or identical with any of the  substances  referred
  to  in  this section, except that these substances shall not include the
  isoquinoline alkaloids of opium.
    (3) Opium poppy and poppy straw.
    (4) Coca leaves and any salt, compound, derivative, or preparation  of
  coca  leaves, and any salt, compound, derivative, or preparation thereof
  which is chemically equivalent or identical with any of these substances
  including cocaine and ecgonine,  their  salts,  isomers,  and  salts  of
  isomers,  except that the substances shall not include decocainized coca
  leaves or extraction of coca leaves, which extractions  do  not  contain
  cocaine or ecgonine.
    (5)  Concentrate  of  poppy straw (the crude extract of poppy straw in
  either liquid, solid or powder  form  which  contains  the  phenanthrene
  alkaloids of the opium poppy).
    (b-1)  Unless  specifically  excepted  or  unless  listed  in  another
  schedule, any material, compound, mixture, or preparation containing any
  of the following, or their salts calculated as the free  anhydrous  base
  or alkaloid, in limited quantities as set forth below:
    (1)  Not  more  than  three  hundred  milligrams  of  dihydrocodeinone
  (hydrocodone) per one hundred  milliliters  or  not  more  than  fifteen
  milligrams  per  dosage  unit, with a fourfold or greater quantity of an
  isoquinoline alkaloid of opium.
    (2)  Not  more  than  three  hundred  milligrams  of  dihydrocodeinone
  (hydrocodone)  per  one  hundred  milliliters  or  not more than fifteen
  milligrams  per  dosage  unit,  with  one  or  more  active  nonnarcotic
  ingredients in recognized therapeutic amounts.
    (c)  Opiates.  Unless  specifically  excepted  or  unless  in  another
  schedule any of the following opiates, including  its  isomers,  esters,
  ethers,  salts  and  salts  of  isomers,  esters and ethers whenever the
  existence of such isomers, esters, ethers, and salts is possible  within
  the  specific  chemical  designation,  dextrorphan  and levopropoxyphene
  excepted:
    (1) Alfentanil.
    (2) Alphaprodine.
    (3) Anileridine.
    (4) Bezitramide.
    (5) Bulk dextropropoxyphene (non-dosage forms).

    (6) Carfentanil.
    (7) Dihydrocodeine.
    (8) Diphenoxylate.
    (9) Fentanyl.
    (10) Isomethadone.
    (11) Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol,
  levomethadylacetate or LAAM).
    (12) Levomethorphan.
    (13) Levorphanol.
    (14) Metazocine.
    (15) Methadone.
    (16) Methadone-intermediate,   4-cyano-2-dimethylamino-4,   4-diphenyl
  butane.
    (17) Moramide-intermediate,                   2-methyl-3-morpholino-1,
  1-diphenylpropane-carboxylic
    (18) Pethidine (meperidine).
    (19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.
    (20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.
    (21) Pethidine-intermediate-C,         1-methyl-4- phenylpiperidine-4-
  carboxylic acid.
    (22) Phenazocine.
    (23) Piminodine.
    (24) Racemethorphan.
    (25) Racemorphan.
    (26) Sufentanil.
    (27) Remifentanil.
    (28) Tapentadol.
    (d) Stimulants. Unless  specifically  excepted  or  unless  listed  in
  another  schedule, any material, compound, mixture, or preparation which
  contains any quantity of the following  substances  having  a  stimulant
  effect  on the central nervous system, including its salts, isomers, and
  salts of isomers:
    (1) Amphetamine.
    (2) Methamphetamine.
    (3) Phenmetrazine.
    (4) Methylphenidate.
    (5) Lisdexamfetamine.
    (e) Depressants. Unless specifically  excepted  or  unless  listed  in
  another  schedule, any material, compound, mixture, or preparation which
  contains any quantity of the following substances  having  a  depressant
  effect  on the central nervous system, including its salts, isomers, and
  salts of isomers whenever the existence  of  such  salts,  isomers,  and
  salts of isomers is possible within the specific chemical designation:
    (1) Amobarbital.
    (2) Glutethimide.
    (3) Pentobarbital.
    (4) Secobarbital.
    (f) Hallucinogenic substances.
    Nabilone:      Another      name     for     nabilone:     (+,-)-trans
  -3-(1,1-dimethylheptyl)-6,  6a,  7,  8,  10,  10a-hexahydro-1-hydroxy-6,
  6-dimethyl-9H-dibenzo{b,d}pyran-9-one.
    (g)  Immediate  precursors.  Unless  specifically  excepted  or unless
  listed  in  another  schedule,  any  material,  compound,   mixture   or
  preparation which contains any quantity of the following substances:
    (1) Immediate precursor to amphetamine and methamphetamine:
    (i)  Phenylacetone Some trade or other names: pheny1-2-propanone; P2P;
  benzyl methyl ketone; methyl benzyl ketone;
    (2) Immediate precursors to phencyclidine (PCP):

    (i) 1-phenylcyclohexylamine;
    (ii) 1-piperidinocyclohexanecarbonitrile (PCC).
    (3) Immediate precursor to fentanyl:
    (i) 4-anilino-N-phenethyl-4-piperidine (ANPP).
    (h)  Anabolic  steroids. Unless specifically excepted or unless listed
  in another schedule, "anabolic steroid" shall mean any drug or  hormonal
  substance,  chemically  and  pharmacologically  related  to testosterone
  (other    than    estrogens,     progestins,     corticosteroids     and
  dehydroepiandrosterone) and includes:
    (1) 3{beta}, 17-dihydroxy-5a-androstane.
    (2) 3{alpha}, 17{beta}-dihydroxy-5a-androstane.
    (3) 5{alpha}-androstan-3,17-dione.
    (4) 1-androstenediol (3{beta},17{beta}-dihydroxy-5{alpha}-androst-1-
  ene).
    (5) 1-androstenediol (3{alpha},17{beta}-dihydroxy-5{alpha}-androst-1-
  ene).
    (6) 4-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-4-ene).
    (7) 5-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-5-ene).
    (8) 1-androstenedione ({5{alpha}}-androst-1-en-3,17-dione).
    (9) 4-androstenedione (androst-4-en-3,17-dione).
    (10) 5-androstenedione (androst-5-en-3,17-dione).
    (11) Bolasterone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyandrost-
  4-en-3-one).
    (12) Boldenone (17{beta}-hydroxyandrost-1, 4,-diene-3-one).
    (13) Boldione (androsta-1,4-diene-3,17-dione).
    (14) Calusterone (7{beta}, 17{alpha}-dimethyl-17{beta}-hydroxyandrost-
  4-en-3-one).
    (15) Clostebol (4-chloro-17{beta}-hydroxyandrost-4-en-3-one).
    (16) Dehydrochloromethyltestosterone     (4-chloro-17{beta}-hydroxy-17
  {alpha}-methyl-androst-1, 4-dien-3-one).
    (17)  {Delta}  1-dihydrotestosterone  (a.k.a.  '1-testosterone')   (17
  {beta}-hydroxy-5{alpha}-androst-1-en-3-one).
    (18) 4-dihydrotestosterone (17{beta}-hydroxy-androstan-3-one).
    (19)      Drostanolone      (17{beta}-hydroxy-2{alpha}-methyl-5{alpha}
  -androstan-3-one).
    (20) Ethylestrenol (17{alpha}-ethyl-17{beta}-hydroxyestr- 4-ene).
    (21) Fluoxymesterone (9-fluoro-17{alpha}-methyl-11{beta},  17  {beta}-
  dihydroxyandrost-4-en-3-one).
    (22)         Formebolone         (2-formyl-17{alpha}-methyl-11{alpha},
  17{beta}-dihydroxyandrost-1, 4-dien-3-one).
    (23) Furazabol (17{alpha}-methyl-17{beta}-hydroxyandrostano
  {2, 3-c}-furazan).
    (24) 13{beta}-ethyl-17{beta}-hyroxygon-4-en-3-one.
    (25) 4-hydroxytestosterone (4, 17{beta}-dihydroxy-androst-4-en-3-one).
    (26)                                      4-hydroxy-19-nortestosterone
  (4,17{beta}-dihydroxy-estr-4-en-3-one).
    (27)                                          desoxymethyltestosterone
  (17{alpha}-methyl-5{alpha}-androst-2-en-17{beta}-ol) (a.k.a., madol).
    (28) Mestanolone                   (17{alpha}-methyl-17{beta}-hydroxy-
  5-androstan-3-one).
    (29) Mesterolone (1{alpha}                    methyl-17{beta}-hydroxy-
  {5{alpha}}-androstan-3-one).
    (30)        Methandienone (17{alpha}-methyl-17{beta}-hydroxyandrost-1,
  4-dien-3-one).
    (31)               Methandriol              (17{alpha}-methyl-3{beta},
  17{beta}-dihydroxyandrost-5-ene).
    (32)     Methenolone      (1-methyl-17{beta}-hydroxy-5{alpha}-androst-
  1-en-3-one).

    (33) 17{alpha}-methyl-3{beta},17{beta}-dihydroxy-5a-androstane.
    (34) 17{alpha}-methyl-3{alpha}, 17{beta}-dihydroxy- 5a-androstane.
    (35) 17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-4-ene.
    (36)     17{alpha}-methyl-4-hydroxynandrolone     (17{alpha}-methyl-4-
  hydroxy-17{beta}-hydroxyestr-4-en-3-one).
    (37)     Methyldienolone      (17{alpha}-methyl-17{beta}-hydroxyestra-
  4,9(10)-dien-3-one).
    (38)    Methyltrienolone    (17{alpha}-methyl-17{beta}-hydroxyestra-4,
  9-11-trien-3-one).
    (39)   Methyltestosterone   (17{alpha}-methyl-17{beta}-hydroxyandrost-
  4-en-3-one).
    (40)   Mibolerone   (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyestr-
  4-en-3-one).
    (41) 17{alpha}-methyl-{Delta} 1-dihydrotestosterone
  (17b{beta}-hydroxy-17{alpha}-methyl-5{alpha}-androst-1-en-3-one)
  (a.k.a. '17-{alpha}-methyl-1-testosterone').
    (42) Nandrolone(17{beta}-hydroxyestr-4-en-3-one).
    (43) 19-nor-4-androstenediol (3{beta},17{beta}-dihydroxyestr -4-ene).
    (44) 19-nor-4-androstenediol (3{alpha},17{beta}-dihydroxyestr-4-ene).
    (45) 19-nor-5-androstenediol (3{beta},17{beta}-dihydroxyestr -5-ene).
    (46) 19-nor-5-androstenediol (3{alpha},17{beta}-dihydroxyestr-5-ene).
    (47)                                 19-nor-4,9(10)-androstadienedione
  (estra-4,9(10)-diene-3,17-dione).
    (48) 19-nor-4-androstenedione (estr-4-en-3,17-dione).
    (49) 19-nor-5-androstenedione (estr-5-en-3,17-dione).
    (50)      Norbolethone      (13{beta},      17{alpha}-diethyl-17{beta}
  -hydroxygon-4-en-3-one).
    (51) Norclostebol (4-chloro-17{beta}-hydroxyestr-4-en-3-one).
    (52)      Norethandrolone       (17{alpha}-ethyl-17{beta}-hydroxyestr-
  4-en-3-one).
    (53)            Normethandrolone            (17{alpha}-methyl-17{beta}
  -hydroxyestr-4-en-3-one).
    (54)       Oxandrolone       (17{alpha}-methyl-17{beta}-hydroxy-2-oxa-
  {5{alpha}}-androstan-3-one).
    (55)      Oxymesterone     (17{alpha}-methyl-4,     17{beta}-dihydroxy
  androst-4-en-3-one).
    (56)     Oxymetholone     (17     {alpha}-methyl-2-hydroxymethylene-17
  {beta}-hydroxy-{5{alpha}}- androstan-3-one).
    (57)     Stanozolol     (17{alpha}-methyl-17{beta}-hydroxy-{5{alpha}}-
  androst-2-eno{3, 2-c}-pyrazole).
    (58)     Stenbolone     (17{beta}-hydroxy-2-methyl-{5{alpha}}-androst-
  1-en-3-one).
    (59)     Testolactone     (13-hydroxy-3-oxo-13,     17-secoandrosta-1,
  4-dien-17-oic acid lactone).
    (60) Testosterone (17{beta}-hydroxyandrost-4-en-3-one).
    (61)      Tetrahydrogestrinone      (13{beta},       17{alpha}-diethyl
  -17{beta}-hydroxygon-4, 9, 11-trien-3-one).
    (62) Trenbolone (17{beta}-hydroxyestr-4, 9, 11-trien-3-one).
    (63)  Any  salt,  ester  or  ether of a drug or substance described or
  listed in this subdivision.
    (i) Subdivision (h) of this section shall not  include  any  substance
  containing  anabolic  steroids  expressly  intended  for  administration
  through implants to cattle  or  other  nonhuman  species  and  that  are
  approved  by  the  federal  food and drug administration solely for such
  use.  Any individual who knowingly and willfully administers to  himself
  or  another person, prescribes, dispenses or distributes such substances
  for other than implantation to  cattle  or  nonhuman  species  shall  be

  subject  to  the  same  penalties  as  a  practitioner  who violates the
  provisions of this section or any other penalties prescribed by law.
    Schedule  III.  (a)  Schedule III shall consist of the drugs and other
  substances, by whatever official name, common or  usual  name,  chemical
  name, or brand name designated, listed in this section.
    (b)  Stimulants.  Unless  specifically  excepted  or  unless listed in
  another schedule, any material, compound, mixture, or preparation  which
  contains  any  quantity  of  the following substances having a stimulant
  effect on the central  nervous  system,  including  its  salts,  isomers
  (whether  optical,  position,  or  geometric), and salts of such isomers
  whenever the existence of such salts, isomers, and salts of  isomers  is
  possible within the specific chemical designation:
    (1)  Those  compounds,  mixtures,  or preparations in dosage unit form
  containing  any  stimulant  substances  listed  in  schedule  II   which
  compounds,  mixtures, or preparations were listed on August twenty-five,
  nineteen  hundred  seventy-one,  as  excepted  compounds   under   title
  twenty-one,  section  308.32  of the code of federal regulations and any
  other drug of the quantitive composition shown in that  list  for  those
  drugs  or which is the same except that it contains a lesser quantity of
  controlled substances.
    (2) Benzphetamine.
    (3) Chlorphentermine.
    (4) Clortermine.
    (6) Phendimetrazine.
    (c) Depressants. Unless specifically  excepted  or  unless  listed  in
  another  schedule, any material, compound, mixture, or preparation which
  contains any quantity of the following substances  having  a  depressant
  effect  on the central nervous system, including its salts, isomers, and
  salts of isomers:
    (1) Any compound, mixture or preparation containing:
    (i) Amobarbital;
    (ii) Secobarbital;
    (iii) Pentobarbital;
  or any salt thereof and one or more other active  medicinal  ingredients
  which are not listed in any schedule.
    (2) Any suppository dosage form containing:
    (i) Amobarbital;
    (ii) Secobarbital;
    (iii) Pentobarbital;
  or  any  salt of any of these drugs and approved by the federal food and
  drug administration for marketing only as a suppository.
    (3) Any substance which contains  any  quantity  of  a  derivative  of
  barbituric acid or any salt thereof.
    (4) Chlorhexadol.
    (5) Lysergic acid.
    (6) Lysergic acid amide.
    (7) Methyprylon.
    (8) Sulfondiethylmethane.
    (9) Sulfonethylmethane.
    (10) Sulfonmethane.
    (11) Tiletamine and zolazepam or any salt thereof. Some trade or other
  names  for  a  tiletamine-zolazepam combination product: Telazol.   Some
  trade or  other  names  for  tiletamine:  2-(ethylamino)  -2-(2-thienyl)
  -cyclohexanone.    Some    trade   or   other   names   for   zolazepam:
  4-(2-fluorophenyl) -6,8-dihydro -1,   3,    8i-trimethylpyrazolo-{3,4-e}
  {1,4} -diazepin-7(1H)-one, flupyrazapon.
    (12)  Gamma  hydroxybutyric  acid,  and salt, hydroxybutyric compound,
  derivative or preparation of gamma hydroxybutyric  acid,  including  any

  isomers,  esters  and  ethers and salts of isomers, esters and ethers of
  gamma hydroxybutyric acid, contained in a  drug  product  for  which  an
  application  has  been  approved  under section 505 of the federal food,
  drug and cosmetic act.
    (13)  Ketamine,   its   salts,  isomers  and salts  of  isomers  (some
  other  names   for   ketamine:   (±)-2-(2-chlorophenyl)-2-(methylamino)-
  cyclohexanone).
    (14) Embutramide.
    (d) Nalorphine.
    (e)  Narcotic  drugs. Unless specifically excepted or unless listed in
  another  schedule,  any  material,  compound,  mixture,  or  preparation
  containing   any  of  the  following  narcotic  drugs,  or  their  salts
  calculated as the free anhydrous base or alkaloid, in limited quantities
  as set forth below:
    (1) Not more than 1.8 grams of codeine per one hundred milliliters  or
  not  more  than  ninety  milligrams  per  dosage  unit, with an equal or
  greater quantity of an isoquinoline alkaloid of opium.
    (2) Not more than 1.8 grams of codeine per one hundred milliliters  or
  not  more  than  ninety  milligrams  per  dosage  unit, with one or more
  active, nonnarcotic ingredients in recognized therapeutic amounts.
    (3) Not  more  than  1.8  grams  of  dihydrocodeine  per  one  hundred
  milliliters or not more than ninety milligrams per dosage unit, with one
  or   more  active  nonnarcotic  ingredients  in  recognized  therapeutic
  amounts.
    (4) Not more than three hundred milligrams of  ethylmorphine  per  one
  hundred milliliters or not more than fifteen milligrams per dosage unit,
  with   one   or  more  active,  nonnarcotic  ingredients  in  recognized
  therapeutic amounts.
    (5) Not more than five hundred milligrams of  opium  per  one  hundred
  milliliters  or  per  one  hundred  grams  or  not more than twenty-five
  milligrams per  dosage  unit,  with  one  or  more  active,  nonnarcotic
  ingredients in recognized therapeutic amounts.
    (6)  Not  more  than  fifty  milligrams  of  morphine  per one hundred
  milliliters  or  per  one  hundred  grams,  with  one  or  more  active,
  nonnarcotic ingredients in recognized therapeutic amounts.
    (7) Buprenorphine in any quantities.
    (f)  Dronabinol  (synthetic)  in sesame oil and encapsulated in a soft
  gelatin capsule in a U.S. Food and Drug Administration approved product.
    Some  other  names  for  dronabinol  include:  (6aR-trans)-6a,  7,  8,
  10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo{b,d} pyran-1-o1, or
  (-)-delta-9-(trans) - tetrahydrocannabinol.
    (g)  Chorionic  gonadotropin.  Unless  specifically excepted or unless
  listed  in  another  schedule  any  material,  compound,   mixture,   or
  preparation which contains any amount of chorionic gonadotropin.
    Schedule  IV.  (a)  Schedule  IV  shall consist of the drugs and other
  substances, by whatever official name, common or  usual  name,  chemical
  name, or brand name designated, listed in this section.
    (b)  Narcotic  drugs. Unless specifically excepted or unless listed in
  another  schedule,  any  material,  compound,  mixture,  or  preparation
  containing   any  of  the  following  narcotic  drugs,  or  their  salts
  calculated as the free anhydrous base or alkaloid, in limited quantities
  as set forth below:
    (1) Not more than  one  milligram  of  difenoxin  and  not  less  than
  twenty-five micrograms of atropine sulfate per dosage unit.
    (2) Dextropropoxyphene   (alpha-(+)-4-dimethylamino-1,   2-diphenyl-3-
  methyl-2-propionoxybutane).
    (c) Depressants. Unless specifically  excepted  or  unless  listed  in
  another  schedule, any material, compound, mixture, or preparation which

  contains any quantity of the following substances, including its  salts,
  isomers,  and  salts  of  isomers  whenever the existence of such salts,
  isomers, and salts of isomers is possible within the  specific  chemical
  designation:
    (1) Alprazolam.
    (2) Barbital.
    (3) Bromazepam.
    (4) Camazepam.
    (5) Chloral betaine.
    (6) Chloral hydrate.
    (7) Chlordiazepoxide.
    (8) Clobazam.
    (9) Clonazepam.
    (10) Clorazepate.
    (11) Clotiazepam.
    (12) Cloxazolam.
    (13) Delorazepam.
    (14) Diazepam.
    (15) Estazolam.
    (16) Ethchlorvynol.
    (17) Ethinamate.
    (18) Ethyl Loflazepate.
    (19) Fludiazepam.
    (20) Flunitrazepam.
    (21) Flurazepam.
    (22) Halazepam.
    (23) Haloxazolam.
    (24) Ketazolam.
    (25) Loprazolam.
    (26) Lorazepam.
    (27) Lormetazepam.
    (28) Mebutamate.
    (29) Medazepam.
    (30) Meprobamate.
    (31) Methohexital.
    (32) Methylphenobarbital (mephobarbital).
    (33) Nimetazepam.
    (34) Nitrazepam.
    (35) Nordiazepam.
    (36) Oxazepam.
    (37) Oxazolam.
    (38) Paraldehyde.
    (39) Petrichoral.
    (40) Phenobarbital.
    (41) Pinazepam.
    (42) Prazepam.
    (43) Temazepam.
    (44) Tetrazepam.
    (45) Triazolam.
    (46) Midazolam.
    (47) Quazepam.
    (48) Zolpidem.
    (49) Dichloralphenazone.
    (50) Zaleplon.
    (51) Zopiclone (eszopiclone).
    (52) Fospropofol.
    (53) Carisoprodol.

    * (d)  Fenfluramine.  Any  material, compound, mixture, or preparation
  which contains any quantity of the following substances,  including  its
  salts,  isomers  (whether optical, position, or geometric), and salts of
  such isomers, whenever the existence of such salts, isomers and salts of
  isomers is possible:
    (1) Fenfluramine.
    * NB  Repealed  upon  the  removal  of  fenfluramine and its salts and
  isomers from Schedule IV of the federal Controlled Substances Act
    (e) Stimulants. Unless  specifically  excepted  or  unless  listed  in
  another  schedule, any material, compound, mixture, or preparation which
  contains any quantity of the following  substances  having  a  stimulant
  effect  on the central nervous system, including its salts, isomers, and
  salts of such isomers:
    (1) Cathine ((+) - norpseudoephedrine).
    (2) Diethylpropion.
    (3) Fencamfamin.
    (4) Fenproporex.
    (5) Mazindol.
    (6) Mefenorex.
    (7)  Pemoline  (including  organometallic   complexes   and   chelates
  thereof).
    (8) Phentermine.
    (9) Pipradrol.
    (10) SPA((-))-1-dimethylamino-1, 2-diphenylethane).
    (11) Modafinil.
    (12) Sibutramine.
    (f) Other substances. Unless specifically excepted or unless listed in
  another  schedule,  any material, compound, mixture or preparation which
  contains any quantity of the following substances, including its salts:
    (1) Pentazocine.
    (2) Butorphanol (including its optical isomers).
    (3) Tramadol in any quantities.
    Schedule V. (a) Schedule V  shall  consist  of  the  drugs  and  other
  substances,  by  whatever  official name, common or usual name, chemical
  name, or brand name designated, listed in this section.
    (b)   Narcotic   drugs   containing   nonnarcotic   active   medicinal
  ingredients.    Any  compound, mixture, or preparation containing any of
  the following narcotic drugs, or their  salts  calculated  as  the  free
  anhydrous  base  or  alkaloid, in limited quantities as set forth below,
  which shall include one or more nonnarcotic active medicinal ingredients
  in sufficient proportion  to  confer  upon  the  compound,  mixture,  or
  preparation  valuable  medicinal qualities other than those possessed by
  narcotic drugs alone:
    (1) Not more than two hundred milligrams of codeine  per  one  hundred
  milliliters or per one hundred grams.
    (2)  Not  more  than  one hundred milligrams of dihydrocodeine per one
  hundred milliliters or per one hundred grams.
    (3) Not more than one hundred  milligrams  of  ethylmorphine  per  one
  hundred milliliters or per one hundred grams.
    (4)  Not  more  than 2.5 milligrams of diphenoxylate and not less than
  twenty-five micrograms of atropine sulfate per dosage unit.
    (5) Not more than one hundred milligrams  of  opium  per  one  hundred
  milliliters or per one hundred grams.
    (6)  Not  more  than  0.5  milligram  of  difenoxin  and not less than
  twenty-five micrograms of atropine sulfate per dosage unit.
    (c) Stimulants. Unless specifically exempted  or  excluded  or  unless
  listed   in  another  schedule,  any  material,  compound,  mixture,  or
  preparation which contains any  quantity  of  the  following  substances

  having  a  stimulant effect on the central nervous system, including its
  salts, isomers and salts of isomers:
    (1) Pyrovalerone.
    (d)  Depressants.  Unless  specifically exempted or excluded or unless
  listed  in  another  schedule,  any  material,  compound,  mixture,   or
  preparation  which  contains  any  quantity  of the following substances
  having a depressant effect on the central nervous system, including  its
  salts, isomers, and salts of isomers:
    (1)   Ezogabine   {N-{2-amino-4-(4-fluorobenzylamino)-phenyl}-carbamic
  acid ethyl ester}.
    (2) Lacosamide {(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide}.
    (3) Pregabalin {(S)-3-(aminomethyl)-5-methylhexanoic acid }.

Disclaimer: These codes may not be the most recent version. New York may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.